丝纳米颗粒的血液兼容性:大小和剂量的影响
Manfred F Maitz1, John D Totten2, Alessia C G Weiss1
1Leibniz-Institut für Polymerforschung Dresden e.V., Division Polymer Biomaterials Science, Hohe Str. 6, 01069 Dresden, Germany.
International journal of pharmaceutics
|December 23, 2025
概括
丝纳米粒子与血液系统的相互作用不同. 幽默级联激活取决于质量度,而颗粒细胞激活取决于颗粒数,指导纳米药物设计用于药物输送.
科学领域:
- 生物材料科学 生物材料科学
- 纳米医学是一种纳米医学.
- 血液动力学 血液动力学
背景情况:
- 纳米医学应用需要了解纳米粒子与循环系统的相互作用.
- 纳米粒子可以触发血液凝结和炎症,但激活和粒子特征之间的关系尚不清楚.
研究的目的:
- 为了研究纳米粒子计数,表面积和质量度如何影响血液激活.
- 通过丝纳米粒子确定凝血,血小板,补充和粒细胞激活的主要驱动因素.
主要方法:
- 在不同度下 (质量,表面积,颗粒数) 在流动的全血中化丝纳米颗粒 (115,240,450 nm).
- 对凝血级联,血小板,补充级联和粒细胞激活的分析.
- 对血蛋白对纳米粒子-细胞相互作用的影响的评估.
主要成果:
- 血蛋白对纳米粒子-免疫细胞关联表现出被动化作用.
- 幽默级联激活主要取决于质量度.
- 颗粒细胞激活显示出对粒子数的线性依赖,表明直接相互作用.
结论:
- 药物输送的纳米粒子设计必须平衡低细胞激活的需要,同时避免血通路激活.
- 诸如曲率和酶复合体组装等因素影响了基本几何参数之外的激活.
相关概念视频
Colloids and Suspensions
Children at play often make suspensions such as mixtures of mud and water, flour and water, or a suspension of solid pigments in water known as tempera paint. These suspensions are heterogeneous mixtures composed of relatively large particles visible to the naked eye or seen with a magnifying glass. They are cloudy, and the suspended particles settle out after mixing. The suspended particles in a suspension settle out after some time of mixing. The separation of particles from a suspension is...
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Bioavailability: Influencing Factors
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...


